trazodone	mcpp	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	none	10737	none
trazodone	mcpp	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	none	10737	none
trazodone	carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	2002
trazodone	carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	2002
trazodone	carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	2002
trazodone	carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	2002
trazodone	Carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	D002220
trazodone	Carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	D002220
trazodone	Carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	D002220
trazodone	Carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		10737	2002	10737	D002220
mcpp	carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	2002
mcpp	carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	2002
mcpp	carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	2002
mcpp	carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	2002
mcpp	Carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	D002220
mcpp	Carbamazepine	2	1	true	positive	Carbamazepine induces CYP3A4.  Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	D002220
mcpp	Carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	D002220
mcpp	Carbamazepine	2	2	true	positive	Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.  		none	2002	none	D002220
